Abstract. Noma is an orofacial gangrene affecting malnourished children and mainly observed in tropical countries, particularly sub-Saharan Africa. Epidemiological data on noma are scarce, but a current estimate of the global incidence is 30,000-40,000 cases per year, with a mortality rate of approximately 85% and a burden of disease calculated to be a loss of 1-10 million disability-adjusted life years.
INTRODUCTION
Noma is an orofacial gangrene, mainly occurring in malnourished children debilitated by disease and living in the developing world. The mortality of noma is high and the survivors harbor such facial deformities that they are often rejected from society and family life. Although known since antiquity, the epidemiology, pathophysiology, and etiology of the disease remain a subject of debate. 1 
MEDICAL HISTORY
Noma is an old companion of humankind. Described by classical and medieval authors, the disease was common in Europe and the United States for centuries. In 1649, noma was included in the first book about neglected diseases, Observationes Medicae de Affectibus Omissis, by Arnoldus Bootius. By the end of the 19th century, noma gradually disappeared from European and U.S. hospitals due to increasing improvements in the welfare of the population. 2 In the rare noma cases that crossed the paths of bacteriologists in the 20th century, no conclusive findings about the causative microorganisms were made until Stewart concluded in 1912 that noma was not a specific infection, but rather an opportunistic one caused by normal oral flora. 3 Shortly after the introduction of sulfonamides and penicillin in the 1940s, it appeared that treatment with antimicrobial drugs reduced the mortality of noma from around 85% to approximately 15%. 4 By contrast, a clear concept with regards to reconstructive noma surgery was developed only 50 years ago. 4 
EPIDEMIOLOGY
The majority of reported noma patients are children 2-7 years of age living in sub-Saharan Africa. Noma cases occur primarily in countries with extreme poverty and low measles vaccination rates. 5 The true global incidence of noma is unknown with estimates ranging from 30,000 to 140,000 individuals. 6, 7 However, the authors have good methodological reasons to support the opinion that an estimated incidence of 30,000-40,000 is closer to the actual reality. The lower incidence was based on a comparison of large numbers of noma and cleft lip patients in a referral hospital with a known incidence of cleft lip in that region, followed by simple extrapolation. The high incidence was based on a few interviews with hospital directors in areas where noma was prevalent, probably a rough guess. With a survival rate of 15% and a life expectancy of 40 more years, a global prevalence of 210,000 noma survivors is estimated. Many cases are not discovered due to weak health care systems, lack of knowledge about noma, stigma, and neglect. Children often die without a diagnosis, treatment, or even a record of their death, as the disease primarily affects the poorest children in remote areas where there is no reliable recording of births, diseases or deaths, and where health care workers do not recognize noma. Risk factors for noma are increasing due to rising economic disparities, higher food prices, more hunger and malnutrition, climatic changes, human immunodeficiency virus (HIV)/acquired immune deficiency syndrome, and national and international neglect. The mortality rate from noma is estimated to be 85% as most children receive no treatment. Data on noma incidence in three sub-Saharan countries reveals the contribution of noma to child mortality as ranging from < 0.5-> 3%, while worldwide, 0.5% of child mortality may result from noma. [7] [8] [9] [10] A common method to quantify the burden of a disease is the measurement of disability-adjusted life years (DALYs). Taking into account premature mortality and disability for surviving noma patients, *Address correspondence to M. Leila Srour, Health Frontiers, PO Box 2548, Laos. E-mail: leila@butterflychildren.org a recent preliminary study by the Swiss Tropical and Public Health Institute, estimated the burden to be between 1-10 million DALYs. 11 This is the first estimate of the global burden from noma and does not include the significant impacts to the household, the stigma, or the psychological effects.
ETIOLOGICAL CONSIDERATIONS
Noma has a multifactorial etiology. A prerequisite is malnutrition, often related to extreme poverty, but other factors are concomitant diseases and poor oral hygiene resulting in gingivitis. Malnutrition is closely correlated with immunity, which may lead to a nutritionally acquired immune deficiency syndrome. 12 This condition is particularly prevalent in children who were preterm and low birth weight babies. Depending on the region in Africa, these infants represent up to 25% of births. 13 The age of the onset of noma corresponds nutritionally to a period of vulnerability coinciding with the period of weaning, with underweight infants particularly at risk. Importantly, weaning corresponds also to the age of the onset of debilitating and immunosuppressive diseases, such as the first malaria crisis or measles.
14 Social factors play a role in the onset of noma, particularly in large families where the mother has grand multiparity and an inadequate nutritional status. The link between the number of past pregnancies and chronic malnutrition in children with noma suggests that it could be related to maternal malnutrition during pregnancy. This may increase the risk for prematurity or low birth weight infants, thus promoting a vicious cycle of repetitive infections and chronic malnutrition and opening the door for noma onset. Various diseases have been described in association with noma, such as malaria, typhus, measles, chickenpox, tuberculosis, and HIV infection. 4, 15, 16 Measles and malaria are the most frequently reported illnesses that precede noma. 4, 5, 17 These diseases often occur during the weaning period and have serious immunosuppressive effects.
Insufficient oral hygiene can facilitate the onset of a necrotizing gingivitis characterized by the presence of some periodontal pathogens and sometimes resulting in the development of noma. [18] [19] [20] 
PATHOGENESIS
Noma is a gangrenous disease affecting young children that rapidly destroys the soft and hard tissues of the face and leads to a massive loss of substance with obvious esthetic prejudice and functional sequelae. 1 This destructive process is divided into several stages for clinical reasons.
CLINICAL SIGNS PRECEDING NOMA
Noma does not start as a necrotizing process. It is preceded by a small intraoral ulcer, an aphtous lesion or, frequently, by acute necrotizing gingivitis (ANG). 20, 21 ANG is characterized by spontaneous bleeding, ulceration of the gingival papillae, pain and sometimes, greyish pseudomembranes ( Figure 1A) . 22, 23 In Africa, there is a high prevalence of ANG in children that ranges from 15% to 60%, depending on the region and the degree of poverty. 21, 24, 25 ANG is facilitated by the lack of dental hygiene, but there is also evidence that malnutrition alone can lead to changes in the oral microflora and to ANG. 26 In general, ANG can be treated by improving oral hygiene, but if the child is undernourished and dental hygiene with follow-up cannot be achieved, antibiotics are recommended. 23, 27 Without treatment, ANG may evolve into a necrotizing stomatitis and result in the destruction of the attached gingival mucosa, the surrounding oral mucosa, and the underlying bone ( Figure 1B ). This stage requires antibiotic treatment. If no treatment is undertaken, the risk of progression toward noma is very high.
ACUTE NOMA: STAGE OF EDEMA AND HALITOSIS
The starting point of noma is defined when facial edema appears in addition to intraoral necrotizing stomatitis (Figure 2 ), accompanied by a typical halitosis often considered as pathognomonic. This stage is short and lasts only a few days.
ACUTE NOMA: STAGE OF NECROSIS
Following the appearance of necrotizing stomatitis and facial edema, a necrotizing infection extends rapidly within a few days into the intraoral mucosa, the facial muscles, the skin, the maxilla, and the mandible. A bluish discoloration of the skin indicates underlying necrosis coming to the surface (Figure 3) . A peculiarity of this gangrene is that it appears to have a self-limiting character ending in a well-demarcated necrosis. On some occasions, the body appears to be able to resist and halt the expansion of the gangrene at a certain stage. Interestingly, some children do not receive treatment and develop relatively small lesions, while others experience huge facial destruction despite appropriate medical treatment. This may be due to differences in the degree of impairment of their immune systems.
ACUTE NOMA: STAGE OF SLOUGHS AND HEALING
After demarcation of the gangrene, the necrotic tissue starts to slough (Figure 4) . At this stage, many patients die due to sepsis. If they do survive and the body has eliminated most necrotic tissue by sloughing, suppuration or sequestration, signs of wound healing appear. During this stage, granulation tissue forms, wound contracture occurs, and both mucosa and epithelium start to grow from the margins of the wound over the granulating surface. Depending on the tissue defect and the health of the patient, this healing process may take weeks or many months. The wound healing process may lead to intraoral constricting bands hampering normal mouth opening (trismus) and, in severe cases, to fibrous or even bony ankylosis of the temporomandibular joint. The dramatic result of this condition is the fact that it will impair the nutrition of children who are already undernourished.
NOMA SEQUELAE
Only approximately 15% of children survive acute noma. [7] [8] [9] Most survivors present with facial deformities and trismus or ankylosis of the mandible, resulting in eating problems, oral incontinence, speech difficulties, and social isolation ( Figure 5 ). At a later age, these contractures often lead to growth disturbances and result in further facial disfigurement and functional impairment. 28 The psychological impact of surviving noma can be easily understood, but it has been rarely studied. 29, 30 MICROBIOLOGY Bacteria have been assumed to play a role due to the rapidity of the evolution of the disease and to the smell of the lesion itself. Different species have been described, such as Borrelia vincentii and Fusiformis fusiformis. 31 The last century saw different schools of thought regarding the etiology of noma. Among the various theories (i.e., the malnutrition and vitamin deficiency theory and the debilitating theory, particularly related to measles), the microbiological theory supposed an interaction between viruses and bacteria with herpesviruses preparing the field for an unknown "noma bacterium" as the trigger organism for the development of the disease. 32, 35 Recent studies using genomic approaches showed an imbalance in the normal oral flora with an overall loss of bacterial diversity. More precisely, acute noma seems to be characterized by the diminution of Capnocytophaga and Fusobacteria genera and by the increase of Prevotella genus. 15, 36, 37 Indeed, Prevotella intermedia was already reported in previous studies undertaken with classical cultures. 35 Prevotella intermedia is a well-known periodontal pathogen in adults, but it has been detected also in the primary dentition of small children. 38, 39 It is frequently recovered from various oral purulent infections in children and also in secondary nosocomial infections. 40, 41 Of note, P. intermedia is always associated with other pathogens and it has never been reported as a monoinfecting agent. Therefore, the proliferation of P. intermedia in noma lesions seems to be the consequence of changes in local ecological conditions due to the development of the disease. These findings invalidate the existence of a single noma pathogen and tend to reconsider noma as a multifactorial, opportunistic disease developing in a relatively normal oral flora in children suffering from chronic malnutrition. 15 
PREVENTIVE MEASURES
Primary prevention of noma can be achieved by economic development, but only if this development ensures that parents can feed their children adequately. Food security programs may be less desirable, but they are effective. However, these preventive measures are political and public health issues. Primary medical prevention of noma consists of measles vaccination programs and the prevention and treatment of concomitant diseases, such as HIV and malaria. Secondary prevention, including the detection and treatment before visible symptoms is difficult and requires surveillance programs in areas of famine and poverty where limited resources are already stretched to the limit by other health priorities.
Tertiary prevention of the disease consists of methods to reduce the negative impact of symptomatic disease, such as disability or death, through treatment and rehabilitation.
Noma is not a common disease, but typically occurs with other neglected diseases and malnutrition. Noma should not be targeted alone, in contrast with vertical programs aiming to eradicate specific health conditions, such as the nearly successful eradication of guinea worm infection. Rather, noma should be included in neglected disease, poverty, malnutrition, and health education programs.
DIAGNOSIS AND TREATMENT
Treatment of acute noma. A medical history of a recent illness combined with the beginning of facial swelling with a foul-smelling discharge from the mouth of a malnourished child is strongly indicative. There are a few clinical pictures that may have a similar appearance and should be considered, such as Buruli ulcer, mumps or angioedema, a tooth abscess, herpetic stomatitis, or local cellulitis. Of note, it is only in this initial, short, nonspecific phase that treatment with antibiotics has the potential to prevent the development of facial gangrene. The development of facial gangrene a few days later will remove any trace of doubt concerning the diagnosis, but antibiotic treatment is unable to limit the extension of the lesion at that time. Treatment consists of three main elements: antibiotics (amoxicillin and metronidazole); hydration and nutritional support; and treatment of concomitant disease/s and deficiencies to prevent death. The choice of these antibiotics is empirical, and not based on culture results and determination of resistance. These facilities are not present in areas where noma is prevalent. Little is known about the presence of multidrug resistant microorganisms in the extremely poor communities where noma is found. Frequent concomitant diseases are pulmonary and gastrointestinal infections, malaria, and HIV, particularly in southern Africa. 15, [42] [43] [44] Local wound care is mandatory with frequent wound dressing, the simple removal of slough with scissors, and extraction of sequesters. Treatment of acute noma is an issue related to secondary health care.
Surgical treatment of noma sequelae. At this stage, the differential diagnosis includes leprosy, leishmaniasis, cutaneous tuberculosis, squamous cell carcinoma, cleft lip, yaws and trauma, which may present as facial deformities mimicking noma. Surgical rehabilitation of noma sequelae is directed at the functional and cosmetic improvement of the face. The basic principle is to release the trismus or ankylosis and to replace lost tissue by transferring local tissue flaps and, when the loss is substantial, from other parts of the body. This requires tertiary health care in specialized health care facilities. At present, this is mainly provided by nongovernmental humanitarian organizations or European hospitals. 28, [45] [46] [47] The social impact of surgical rehabilitation is rewarding with better chances for education, employment and marriage after surgery. 29, 30 NOMA: A NEGLECTED DISEASE AND A VIOLATION OF HUMAN RIGHTS Noma remains a neglected disease in tropical medicine, in local health policies and in neglected tropical disease programs. None of the many institutional reports, for example, from the World Health Organization (WHO), has included noma in their estimations of the global burden of diseases, although a recent first and rough estimation of the burden of the disease of noma (1-10 million DALYs) qualifies the disease to be fully recognized as a neglected tropical disease. 48 The continued existence of noma is evidence that the most vulnerable children lack the basic right to food. In 2012, the United Nations Human Rights Council Advisory Committee cited children affected by noma as an example of the effects of severe malnutrition and childhood diseases as follows: "Noma, the face of poverty, represents the worst violations of the rights of the child." 49, 50 CONCLUSIONS Noma is a noncontagious infectious disease with a relatively high burden of disease and should be part of neglected tropical disease programs. The neglect of noma is a major humanitarian concern that requires the attention of national and international organizations. Noma is a biological indicator of extreme poverty, malnutrition, and human rights violations affecting the most vulnerable children. The vicious cycle of noma neglect begins with WHO and continues without awareness or monitoring, which keeps the disease unknown throughout the world. Therefore, noma should be on the WHO list of Neglected Tropical Diseases. Wherever noma is found, primary health care is needed to improve nutrition, immunizations, exclusive breastfeeding, hygiene, sanitation, and dental care. Global monitoring and research should be supported. The stakeholders, their responsibilities and actions are summarized in Table 1 .
If the end of neglect of this preventable childhood disease will lead to the global eradication of noma is a bigger question related to the ever increasing number of human beings on this planet and the concomitant increasing scarcity of resources.
